Seòmar agus comataidhean

Tovorafenib does not currently have a marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA). Before a company can place a medicine on the market in the UK it has to obtain regulatory approval by submitting data demonstrating the quality, safety and efficacy of the medicine in terms of treating a specified condition. This data is derived from clinical trials. If a marketing authorisation is granted, the Scottish Medicines Consortium (SMC) would welcome a submission for tovorafenib. The Scottish Government is aware that there is an international, phase 3 clinical trial looking at tovorafenib for the first line treatment of paediatric low-grade glioma which is open to people who meet the eligibility criteria. It is the responsibility of the clinician in charge of a patient’s care to advise on what treatment options may be available.

The Scottish Government has been working with CoSLA to look at options for removing non residential care charging. Given pressures being faced across the system, this has focussed on financial analysis but has also included modelling on potential increases in the number of people accessing social care should charges be removed.

The Scottish Government continues to discuss options on non-residential social care charges with CoSLA and other partners whilst acknowledging the challenging financial context and ongoing pressure across the system. The charges people pay can vary across the country and it is important to fully assess impact within this complex delivery environment for people facing charges before agreeing the possible approach to removal.

The Scottish Government welcomes the work done by Carers Scotland and IPPR Scotland on a Minimum Income Guarantee pilot for unpaid carers.

We recognise the importance of unpaid care, which is why we made a Programme for Government commitment to work with the independent Minimum Income Guarantee Expert Group to model a Minimum Income Guarantee for unpaid carers.

The Scottish Government will carefully consider how this and wider work on a Minimum Income Guarantee for unpaid carers is incorporated into the independent Expert Group’s report and recommendations that we expect to see shortly.

The Scottish Government is working with COSLA to explore possible options for removing non-residential social care charges within the current budget settlement as part of ongoing social care improvement and reform activity.

Public Health Scotland (PHS) are responsible for the delivery of the Fracture Liaison Services (FLS) audit which was commissioned by Scottish Government in July 2024. PHS has informed Scottish Government that there was a delay in recruitment required for audit development, however this has now been completed. PHS are now working at pace in line with the business case requirements to establish this new audit.

A national HIV testing week was carefully considered by the HIV Transmission Elimination Scoping Group, including clinical and public health experts, who did not recommend that it should be prioritised in the short to medium term. Based on the Group’s advice, our HIV Transmission Elimination Delivery Plan 2023-26 sets out our approach to addressing stigma and promoting HIV testing on a consistent, year-round basis. However, the Scottish Government has committed to reviewing the potential costs and benefits of a national testing week once priority actions to expand capacity and improve access to testing have been progressed.

I refer the member to the answer to question S6W-34901 on 3 March 2025. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.

HIV transmission elimination is funded as part of the wider Sexual Health and Blood Borne Virus (SHBBV) budget. Many of the interventions which support this have wider impacts on sexual health improvement and blood borne virus elimination.

Prior to the Sexual Health and Blood Borne Virus Action Plan 2023-26, the SHBBV Framework was supported by approximately £2 million, to support delivery of the outcomes between 2018 and 2021. This funding came to an end in March 2021.

Due to the pandemic, during 2021-22 interim arrangements were made for third sector organisations to continue to receive funding under the Framework from an SHBBV budget of around £0.8 million, with an additional £0.5 million allocated as part of COVID-19 planning to support recovery actions.

The SHBBV budget is approximately £1.7m per year since 2023-24. This supports delivery of the Sexual Health and Blood Borne Virus Action Plan 2023-26, including a range of projects focused on HIV transmission elimination (details of which were published with the Plan).

Other specific projects the Scottish Government has funded include the national HIV anti-stigma campaign (£250,000 in 2022-23), the development of an ePrEP clinic (£400,000 in 2022-23), emergency department opt-out testing pilots (£145,000 in 2023-24), online postal self-sampling for sexually transmitted infections and HIV (£119,000 in 2023-24 and £300,000 in 2024-25), the Terrence Higgins Trust HIV self-test service (around £120,000 per year) and a workforce education project led by Waverley Care to reduce stigma in health and social care settings (£95,000 in 2024-25).

As promised in the Scottish Parliament debate on Young Carers Action Day on 14 March 2024, I have tasked my officials with looking at the feasibility of the Scottish Government committing to the Young Carer Covenant. The Covenant’s overarching principles are cross policy in nature, and touch on many aspects of the Scottish Government work.

This work is ongoing. I will write to the member to advise her of the outcome.